This breakthrough has positioned semaglutide as a frontrunner in the fight against obesity, a growing global health concern
In endurance sports, where thinness is often wrongly associated with performance, its easy to see why some athletes are drawn to the idea of a pharmaceutical shortcut
Scott Steele: So Kristen, we don't have to go to the individual medications themselves, but in broad terms, can you talk about the different GLP-1 options available right now
The Beck Depression InventoryII (BDI-II) [130] provides a more detailed assessment than both the PHQ-9 and the HADS, but it requires more time to complete (21 items) and is not freely accessible due to copyright restrictions
In the most recent clinical trials, less than 5% of people discontinued GLP-1 medications because of side effects
Its ability to stimulate collagen synthesis, glycosaminoglycan production, and balanced tissue remodeling is supported by multiple studies